Navigation Links
CNA Finance Initiates Research Coverage On Cancer Genetics
Date:8/24/2017

CNA Finance Chief Research Analyst, Kenny Soulstring, today announced that the stock market news outlet had initiated coverage on Cancer Genetics, a company that has key value drivers already in place to take advantage of opportunities in the $11 billion oncology testing market. The company's recent value enhancing acquisition of vivoPharm is expected to increase current revenues by over $5 million in the fiscal year and will add approximately 55 new oncology focused projects to the in-progress pipeline of over 170 active studies.

According to Kenny Soulstring, "In addition to additional partnership opportunity, which is likely according to the company's recent conference call, the vivoPharm acquisition expands the company's discovery and early development revenue base with a highly complementary set of biotechnology and pharmaceutical customers, with substantial opportunity to develop alliances in both Europe and the Asia-Pacific."

In addition, Soulstring believes that Cancer Genetics is well placed in an industry that is increasing the revenue opportunity exponentially, with an overall oncology testing market expected to eclipse $450 billion on a global scale by the end of the decade. Soulstring also cites that Cancer Genetics is building a global footprint. completing four transformative and accretive acquisitions that provide significant strategic opportunity moving forward.

With Cancer Genetics concentrating on both oncology and immuno-oncology, the newly combined company (with vivoPharm) will provide client specific services ranging from early compound selection to developing comprehensive sets of both in-vitro and in-vivo data and analysis. More importantly, for customers in need of supporting data for Investigational New Drug "IND" applications, the services offered by CGIX hold immense value to clients, who rely on the specialization and unique data profiles to support an IND.

To read CNA Finance's complete research coverage on Cancer Genetics, click here.

Read the full story at http://www.prweb.com/releases/2017/08/prweb14625993.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. CNA Finance Initiates Research Coverage On Advanced Medical Isotope Corporation
2. CNA Finance Initiates Research Coverage On Green Spirit
3. CNA Finance Initiates Research Coverage On NuLife Sciences
4. CNA Finance Provides Research Update On Aytu Bioscience And Natesto®
5. CNA Finance Initiates Research Coverage On Next Group Holdings, Inc.
6. CNA Finance Initiates Research Coverage On Aytu Bioscience
7. CNA Finance Initiates Research Coverage On Interpace Diagnostics
8. Oxford Finance Provides $20 Million Senior Debt Facility to Cerapedics Inc.
9. Oxford Finance Provides $10 Million Senior Debt Facility to Oxford BioTherapeutics
10. Biotech finance expert joins Renova Therapeutics as CFO
11. Oxford Finance Provides $3 Million Senior Debt Facility to MDRejuvena
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2018)... ... August 01, 2018 , ... ... significant impact of a proprietary biofield energy treated supplement that potentially improves ... biomarkers for systemic and organ-specific inflammation, as well as, immune function response. ...
(Date:7/27/2018)... ... July 27, 2018 , ... ... Group (BRAG®) and representatives of the Biotechnology Innovation Organization (BIO) met with ... white paper, “Proposal for a Toxic Substances Control Act (TSCA) Inventory Representation ...
(Date:7/25/2018)... Calif. (PRWEB) , ... July 25, 2018 , ... ... in vivo research utilizing its state-of-the-art Digital Vivarium™ and Vium Cloud approach to ... Ph.D., to Chief Scientific Officer. Additionally, the company announced the appointment of Jeff ...
(Date:7/24/2018)... Neb. (PRWEB) , ... July 23, 2018 , ... ... impact of a biofield energy treated nutraceutical to increase immunity and improve anti-inflammatory, ... as, immune function response assessed in the preclinical research were significantly reduced. Results ...
Breaking Biology Technology:
(Date:8/7/2018)... ... August 07, 2018 , ... Nanomedical ... announces a new publication titled, “Synthetic Molecules for Disruption of the Myc ... prominently features use of Agile R100, described as a “ field-effect transistor (Bio-FET) ...
(Date:8/1/2018)... ... , ... Dr. Asher Kimchi, Founder and Chairman of the International Academy ... at the 23rd World Congress on Heart Disease held in Boston, MA, USA. In ... Distinguished Fellowship Awards. , Dr. Asher Kimchi, together with Chairman Dr. John A. Elefteriades, ...
(Date:7/31/2018)... ... July 31, 2018 , ... ACEA Biosciences, is a privately owned biotechnology company ... introduced the xCELLigence RTCA S16, which the ideal entry level model for exploratory studies ... S16can be placed in any standard CO2 tissue culture incubator. The user friendly ...
Breaking Biology News(10 mins):